University of Lyon, Centre Léon Bérard, Department of Radiation Oncology, Lyon, France.
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):38-43. doi: 10.1016/j.ijrobp.2009.04.019. Epub 2010 Feb 18.
To determine predictive factors of late radiation fibrosis (RF) after conformal radiotherapy (3D-RT) in non-small cell lung cancer (NSCLC).
Ninety-six patients with Stage IA-IIIB NSCLC were included in a prospective trial. Clinical evaluation, chest X-ray, and pulmonary functional tests including diffusion parameters were performed before and 6 months after radiotherapy. An independent panel of experts prospectively analyzed RF, using Late Effects in Normal Tissues-Subjective, Objective, Management and Analytic scales classification. Logistic regression analysis was performed to identify relationships between clinical, functional, or treatment parameters and incidence of RF. Variations of circulating serum levels of pro-inflammatory (interleukin-6, tumor necrosis factor alpha, tumor growth factor beta1) and anti-inflammatory (interleukin-10) cytokines during 3D-RT were examined to identify correlations with RF.
Of the 96 patients included, 72 were evaluable for RF at 6 months. Thirty-seven (51.4%) developed RF (Grade >or=1), including six severe RF (Grades 2-3; 8.3%). In univariate analysis, only poor Karnofsky Performance Status and previous acute radiation pneumonitis were associated with RF (p < 0.05). Dosimetric factors (mean lung dose, percentage of lung volume receiving more than 10, 20, 30, 40, and 50 Gy) were highly correlated with RF (p < 0.001). In multivariate analysis, previous acute radiation pneumonitis and dosimetric parameters were significantly correlated with RF occurrence. It was not significantly correlated either with cytokines at baseline or with their variation during 3D-RT.
This study confirms the importance of dosimetric parameters to limit the risk of RF. Contrary to acute radiation pneumonitis, RF was not correlated to cytokine variations during 3D-RT.
确定非小细胞肺癌(NSCLC)患者行三维适形放疗(3D-RT)后迟发性放射性纤维化(RF)的预测因素。
96 例 I 期至 IIIB 期 NSCLC 患者纳入一项前瞻性试验。在放疗前后 6 个月进行临床评估、胸部 X 线检查和包括弥散参数在内的肺功能检查。一个独立的专家小组使用晚期正常组织主观、客观、管理和分析量表分类,前瞻性地分析 RF。进行逻辑回归分析,以确定临床、功能或治疗参数与 RF 发生率之间的关系。在 3D-RT 期间,检测循环血清中促炎(白细胞介素-6、肿瘤坏死因子-α、肿瘤生长因子-β1)和抗炎(白细胞介素-10)细胞因子的水平变化,以确定与 RF 的相关性。
96 例患者中,72 例可在 6 个月时评估 RF。37 例(51.4%)发生 RF(等级>或=1),其中 6 例为严重 RF(等级 2-3;8.3%)。单因素分析显示,只有较差的 Karnofsky 表现状态和既往急性放射性肺炎与 RF 相关(p < 0.05)。剂量学因素(平均肺剂量、接受超过 10、20、30、40 和 50 Gy 肺体积的百分比)与 RF 高度相关(p < 0.001)。多因素分析显示,既往急性放射性肺炎和剂量学参数与 RF 发生显著相关,与基线时的细胞因子或 3D-RT 期间的细胞因子变化均无显著相关性。
本研究证实剂量学参数对限制 RF 风险很重要。与急性放射性肺炎不同,RF 与 3D-RT 期间细胞因子的变化无相关性。